These results show that selective LmPTR1 inhibitors alone do not exhibit antiparasitic activity and suggest that the combination of DHFR inhibitors with PTR1 inhibitors might be an effective treatment for leishmaniasis and possibly other parasitic diseases [68]. Here, DHFR is linked to leishmaniasis.